Heart failure & cardiomyopathies

Dose-Response Associations of Exercise Modalities With Cardiorespiratory Fitness in Heart Failure: A Systematic Review and Bayesian Network Meta-Analysis

Eur J Prev CardiolPublished Systematic review and Bayesian network meta-analysis

Authors' conclusion

The exercise dose-response relationship in heart failure follows an Emax curve, with distinct dose-benefit profiles across different exercise modalities. Based on the current evidence, the following preliminary considerations may be offered: for patients with limited exercise tolerance, MBT may be considered as one of the preferred options; for those with moderate exercise tolerance, IAT+RT or CAT+RT may be suitable choices; for patients with good exercise tolerance, IAT or RT may be considered; and for patients with comorbid obesity, CAT may be incorporated into a comprehensive management program.

Study context

Population
Patients with heart failure in randomized controlled trials comparing exercise interventions with controlspatients in 100 trials
Participants
5,353 patients
Comparison
Exercise interventions compared with controls; effects of exercise modalities and standardized doses (MET-min/week) on VO2peak
Outcome
Dose-response relationship for VO2peak
Methodological detailsBayesian model-based network dose-response meta-analysis, randomized controlled trials
  • Bayesian model-based network dose-response meta-analysis
  • Randomized controlled trials

Pooled result

As reported in the abstract

ED50 values

80-90 MET-min/week

Weekly dose of 500 MET-min yielded considerable benefit

500 MET-min

Dose approaching maximal benefit for nearly all modalities

750-1000 MET-min

Further pooled results

Emax

OutcomeIATRTIAT+RT
Top three ranked interventions (Emax, VO2peak)3.50 (95% CrI 2.49–4.60)3.66 (95% CrI 1.96–5.85)3.49 (95% CrI 1.26–5.79)

Original publication

Dose-Response Associations of Exercise Modalities With Cardiorespiratory Fitness in Heart Failure: A Systematic Review and Bayesian Network Meta-Analysis. Eur J Prev Cardiol. Published 23 October 2026. doi:10.1093/eurjpc/zwag560

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.